Delivery Order SPE2DB22D1106-SPE2DB25FEJV1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Latuda 80 mg tablets (30-count units) with a ceiling value of $5,922.45. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a single transaction under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The award was competitively procured with no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Latuda 40 mg tablets (30-count units) valued at $7,754.48 under a firm fixed price contract structure. This non-set-aside award was competitively procured and is scheduled for completion by July 15, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and will fulfill this order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Latuda 60 mg tablets in a quantity of 30 units. This is a firm fixed price delivery order with a ceiling value of $5,418.64 and an ultimate completion date of September 11, 2025. The contract was awarded without a set-aside designation through competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 2, 2025, for the supply of Latuda 60 mg tablets (30-count packaging) with a ceiling value of $6,445.00 under a firm fixed price contract. This non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a total value of $999,999,999.00 and extends through December 2026. The order is to be fulfilled...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Latuda 40 mg tablets (quantity: 30 units) under a firm fixed price contract with a ceiling value of $10,349.66. The order is scheduled for completion by September 23, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Latuda 60 mg tablets (30-count units) with a ceiling value of $29,470.00 under firm fixed pricing. This non-set-aside, competitively awarded delivery order is scheduled for completion by August 5, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,653.85 to AmerisourceBergen Drug Corp for the supply of Latuda 40 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on November 13, 2025, with an ultimate completion date of November 14, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Latuda 20 mg tablets (30-count) valued at $4,191.82 under a firm fixed-price contract. The award was made on May 14, 2025, with an ultimate completion date of May 15, 2025, and the product will be performed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting the contractor's established capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Latuda 120 mg tablets (30-count) with a ceiling value of $41,891.62. This firm fixed-price contract, awarded on September 8, 2025, with a completion date of September 9, 2025, represents a non-competitive set-aside delivery order issued under DLA's broader pharmaceutical procurement framework. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $6,978.90 delivery order to AmerisourceBergen Drug Corp for Latuda 40 mg tablets (30-count units) on September 18, 2025, with a completion date of September 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation and...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEJV1Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Latuda 60 mg tablets in quantities of 30 units, with a contract ceiling value of $3,132.62. This firm fixed-price delivery order is non-competitive and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply arrangements with DLA. The contract is scheduled for completion by April 22, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen leverages this comprehensive IDV to supply a broad spectrum of medications and medical supplies to military healthcare systems and other government agencies including the Defense Health Agency and U.S. Coast Guard. The Latuda delivery exemplifies the company's role in providing critical pharmaceutical products across multiple therapeutic domains to support military and veteran healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 4/21/25 |